Home Cart Sign in  
Chemical Structure| 506-12-7 Chemical Structure| 506-12-7

Structure of Heptadecanoic Acid
CAS No.: 506-12-7

Chemical Structure| 506-12-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Heptadecanoic acid is an endogenous metabolite.

Synonyms: C17:0 Fatty acid; C17:0; Margarinic acid

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Heptadecanoic Acid

CAS No. :506-12-7
Formula : C17H34O2
M.W : 270.45
SMILES Code : CCCCCCCCCCCCCCCCC(O)=O
Synonyms :
C17:0 Fatty acid; C17:0; Margarinic acid
MDL No. :MFCD00002751
InChI Key :KEMQGTRYUADPNZ-UHFFFAOYSA-N
Pubchem ID :10465

Safety of Heptadecanoic Acid

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319
Precautionary Statements:P264-P280-P302+P352+P332+P313+P362+P364-P305+P351+P338+P337+P313

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
human microvascular endothelial cells (HMVEC) 100 µM 18 hours MA inhibits Piezo1 currents by increasing the mechanical threshold required for activation. Nat Commun. 2019 Mar 13;10(1):1200
mouse neuro-2a (N2A) cells 100 µM 18 hours MA inhibits Piezo1 currents by increasing the mechanical threshold required for activation. Nat Commun. 2019 Mar 13;10(1):1200
colonic circular muscle cells 50 and 100 μM to investigate the effects of C17:0 and C18:0 on colonic muscle contraction, showing they dose-dependently enhanced contraction amplitudes Microbiome. 2018 Jun 14;6(1):107
primary mouse hepatocytes 125 µM 24 or 48 hours To evaluate the effects of heptadecanoic acid on lipid metabolism and inflammatory signaling in hepatocytes. Results showed that C17:0 treatment increased the expression of lipogenic genes but had no effect on insulin-stimulated AKT phosphorylation, while suppressing JAK2/STAT3 signaling. Nutrients. 2023 Apr 24;15(9):2052

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6JRj mice High-fat diet-induced hepatic steatosis and insulin resistance model Dietary supplementation 5% For 20 weeks To assess the effects of long-term heptadecanoic acid supplementation on high-fat diet-induced hepatic steatosis and insulin resistance. Results showed that C17:0 supplementation did not improve hepatic lipid accumulation or insulin resistance and had no significant effect on hepatic lipid metabolism. Nutrients. 2023 Apr 24;15(9):2052

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.70mL

0.74mL

0.37mL

18.49mL

3.70mL

1.85mL

36.98mL

7.40mL

3.70mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories